After revolutionizing the weight-loss drug market, Novo Nordisk (NVO) and Eli Lilly (LLY) are setting their sights on heart ...
This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...
Coffee and the caffeine in it can interact with some drugs. Learn more about which drugs you should not take with coffee.
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
An experimental drug could be game-changing for millions of Americans with a higher genetic risk of cardiovascular disease.
At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner ...
The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...
Drugs from Novartis, Amgen and now Lilly have proven powerfully effective at reducing Lp(a). Whether that will translate to a ...
Patients who were counseled on heart medications and lifestyle modifications by specially trained nurses were 30% less likely ...
Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...
He needed a stent to keep the artery open and blood flowing. But when his doctor tried to place it, he couldn't. Matt's ...
Discover the hidden health issues often misdiagnosed as anxiety that could be causing your symptoms, from thyroid disorders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results